Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience

Haemophilia

Volumn 18, Issue 1, 2012, Pages 69-74

  Alioglu, B ^a   Selver, B ^a   Ozsoy, H ^a   Koca, G ^a   Ozdemir, M ^a   Dallar, Y ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

25 hydroxy vitamin D 3; Bone mineral density; Bone specific alkaline phosphatase; Calcitonin; Haemophilia; Osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; PARATHYROID HORMONE;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE REMODELING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEMOPHILIA A; HUMAN; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TURKEY (BIRD); VITAMIN BLOOD LEVEL;

ADOLESCENT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIFEDIOL; CALCITONIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOPHILIA A; HUMANS; MALE; OSTEOCALCIN; TURKEY; YOUNG ADULT;

EID: 84355162266     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02587.x     Document Type: Article

References (29)

1. Genant HK, Cooper C, Poor G et al. Interim report and recommendation of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999; 10: 259-64.
2. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 2000; 17: 1-45.
3. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest 2005; 115: 3318-25.
4. Sambrook P, Cooper C. Osteoporosis. Lancet 2006; 367: 2010-8.
5. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004; 127: 127-39.
6. Cummings SR, Melton LJ 3rd. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761-7.
7. Hoyer LW. Haemophilia A. N Engl J Med 1994; 330: 38-47.
8. Gallacher SJ, Deighan C, Wallace AM et al. Association of severe HA with osteoporosis: a densitometric and biochemical study. Q J Med 1994; 87: 181-6.
9. Wallny TA, Scholz DT, Oldenburg J et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia 2007; 13: 79-84.
10. Nair AP, JiJina F, Ghosh K et al. Osteoporosis in young haemophiliacs from Western India. Am J Hematol 2007; 82: 453-7.
11. Hacker MR, Funk SM, Manco-Johnson MJ. The Colorado Haemophilia Paediatric Joint Physical Examination Scale: normal values and interrater reliability. Haemophilia 2007; 13: 71-8.
12. Lewiecki EM, Watts NB, McClung MR et al. International Society for Clinical Densitometry. Official positions of theInternational Society for Clinical Densitometry. J Clin Endocrinol Metab 2004; 89: 3651-5.
13. Smit C, Rosendaal FR, Varekamp I et al. Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85. BMJ 1989; 298: 235-8.
14. Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995: Association of Hemophilia Clinic Directors of Canada. Haemophilia 1998; 4: 714-20.
15. Michael Soucie J, Christy C, Robert L et al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 2004; 103: 2467-73.
16. Heany R. Pathophysiology of osteoporosis. Endocrinol Metab Clin North Am 1998; 27: 255-6.
17. Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991; 73: 1332-9.
18. Barnes C, Wong P, Egan B et al. Reduced bone density among children with severe haemophilia. Pediatrics 2004; 114: 177-81.
19. Tsuneoka K, Tameda Y, Takase K, Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996; 31: 669-78.
20. Olsson R, Johansson C, Lindstedt G, Mellstrom D. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 1994; 29: 753-6.
21. Kovacs CS. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apher Sci 2008; 38: 33-40.
22. Tlacuilo-Parra A, Morales-Zambrano M, Tostado-Rabago N, Esparza-Flores MA, Lopez-Guido B, Orozco-Alcala J. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol 2008; 140: 562-7.
23. Christoforidis A, Economou M, Farmaki E, Tzimouli V, Gombakis N, Athanassiou-Metaxa M. Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia. Ann Hematol 2010; 89: 837-8.
24. Katsarou O, Terpos E, Chatzismalis P et al. A Karafoulidou. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Ann Hematol 2010; 89: 67-74.
25. Tlacuilo-Parra A, Villela-Rodriguez J, Garibaldi-Covarrubias R, Soto-Padilla J, Orozco-Alcala J. Bone turnover markers and bone mineral density in children with haemophilia. Haemophilia 2011; 17: 657-61.
26. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-95.
27. Batch JA, Couper JJ, Roda C, Cowell CT, Zacharin M. Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health 2003; 39: 88-92.
28. Fuchs RK, Snow CM. Gains in hip bone mass from high-impact training are maintained: a randomized controlled trial in children. J Pediatr 2002; 141: 357.
29. McKay H, Petit M, Schutz R, Prior J, Barr S, Khan K. Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in pre-pubescent and early pubescent children. J Pediatr 2000; 136: 156-62.